Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma

Cellular senescence plays a crucial role in tumorigenesis, development and immune modulation in cancers. However, to date, a robust and reliable cellular senescence-related signature and its value in clinical outcomes and immunotherapy response remain unexplored in lung adenocarcinoma (LUAD) patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Weihao Lin, Xin Wang, Zhen Wang, Fei Shao, Yannan Yang, Zheng Cao, Xiaoli Feng, Yibo Gao, Jie He
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/b6371768b2ec43edbdc17fac425ad0f4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b6371768b2ec43edbdc17fac425ad0f4
record_format dspace
spelling oai:doaj.org-article:b6371768b2ec43edbdc17fac425ad0f42021-11-16T05:18:04ZComprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma2296-634X10.3389/fcell.2021.780461https://doaj.org/article/b6371768b2ec43edbdc17fac425ad0f42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.780461/fullhttps://doaj.org/toc/2296-634XCellular senescence plays a crucial role in tumorigenesis, development and immune modulation in cancers. However, to date, a robust and reliable cellular senescence-related signature and its value in clinical outcomes and immunotherapy response remain unexplored in lung adenocarcinoma (LUAD) patients. Through exploring the expression profiles of 278 cellular senescence-related genes in 936 LUAD patients, a cellular senescence-related signature (SRS) was constructed and validated as an independent prognostic predictor for LUAD patients. Notably, patients with high SRS scores exhibited upregulation of senescence-associated secretory phenotype (SASP) and an immunosuppressive phenotype. Further analysis showed that SRS combined with immune checkpoint expression or TMB served as a good predictor for patients’ clinical outcomes, and patients with low SRS scores might benefit from immunotherapy. Collectively, our findings demonstrated that SRS involved in the regulation of the tumor immune microenvironment through SASP was a robust biomarker for the immunotherapeutic response and prognosis in LUAD.Weihao LinXin WangZhen WangFei ShaoYannan YangZheng CaoXiaoli FengYibo GaoYibo GaoJie HeJie HeFrontiers Media S.A.articlelung adenocarcinomacellular senescencesenescence-associated secretory phenotypetumor microenvironmentprognosisimmunotherapyBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic lung adenocarcinoma
cellular senescence
senescence-associated secretory phenotype
tumor microenvironment
prognosis
immunotherapy
Biology (General)
QH301-705.5
spellingShingle lung adenocarcinoma
cellular senescence
senescence-associated secretory phenotype
tumor microenvironment
prognosis
immunotherapy
Biology (General)
QH301-705.5
Weihao Lin
Xin Wang
Zhen Wang
Fei Shao
Yannan Yang
Zheng Cao
Xiaoli Feng
Yibo Gao
Yibo Gao
Jie He
Jie He
Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
description Cellular senescence plays a crucial role in tumorigenesis, development and immune modulation in cancers. However, to date, a robust and reliable cellular senescence-related signature and its value in clinical outcomes and immunotherapy response remain unexplored in lung adenocarcinoma (LUAD) patients. Through exploring the expression profiles of 278 cellular senescence-related genes in 936 LUAD patients, a cellular senescence-related signature (SRS) was constructed and validated as an independent prognostic predictor for LUAD patients. Notably, patients with high SRS scores exhibited upregulation of senescence-associated secretory phenotype (SASP) and an immunosuppressive phenotype. Further analysis showed that SRS combined with immune checkpoint expression or TMB served as a good predictor for patients’ clinical outcomes, and patients with low SRS scores might benefit from immunotherapy. Collectively, our findings demonstrated that SRS involved in the regulation of the tumor immune microenvironment through SASP was a robust biomarker for the immunotherapeutic response and prognosis in LUAD.
format article
author Weihao Lin
Xin Wang
Zhen Wang
Fei Shao
Yannan Yang
Zheng Cao
Xiaoli Feng
Yibo Gao
Yibo Gao
Jie He
Jie He
author_facet Weihao Lin
Xin Wang
Zhen Wang
Fei Shao
Yannan Yang
Zheng Cao
Xiaoli Feng
Yibo Gao
Yibo Gao
Jie He
Jie He
author_sort Weihao Lin
title Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
title_short Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
title_full Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
title_fullStr Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
title_full_unstemmed Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
title_sort comprehensive analysis uncovers prognostic and immunogenic characteristics of cellular senescence for lung adenocarcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b6371768b2ec43edbdc17fac425ad0f4
work_keys_str_mv AT weihaolin comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT xinwang comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT zhenwang comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT feishao comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT yannanyang comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT zhengcao comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT xiaolifeng comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT yibogao comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT yibogao comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT jiehe comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
AT jiehe comprehensiveanalysisuncoversprognosticandimmunogeniccharacteristicsofcellularsenescenceforlungadenocarcinoma
_version_ 1718426688700809216